(Q43546448)

24 November 2017

title

Effects of pranlukast, a leukotriene receptor antagonist, on airway inflammation in mild asthmatics (English)

1 reference

24 November 2017

0 references

0 references

1 reference

K Yamauchi

1

1 reference

24 November 2017

Y Tanifuji

2

1 reference

24 November 2017

L H Pan

3

1 reference

24 November 2017

T Yoshida

4

1 reference

24 November 2017

S Sakurai

5

1 reference

24 November 2017

S Goto

6

1 reference

24 November 2017

S Kuroda

7

1 reference

24 November 2017

H Kobayashi

8

1 reference

24 November 2017

H Inoue

9

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

24 November 2017

1 reference

24 November 2017

volume

38

1 reference

24 November 2017

issue

1

1 reference

24 November 2017

page(s)

51-57

1 reference

Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Increased nitric oxide in exhaled air of asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Use of induced sputum cell counts to investigate airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Cellular characteristics of sputum from patients with asthma and chronic bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Airway remodeling and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Nitric oxide and asthmatic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Epithelially derived endothelin and nitric oxide in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

A 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

The mechanics of airway narrowing in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Eosinophils as a potential source of platelet-derived growth factor B-chain (PDGF-B) in nasal polyposis and bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Induced sputum to assess airway inflammation in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Increased levels of nitric oxide derivatives in induced sputum in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? No

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast Asthma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Single-breath nitric oxide measurements in asthmatic patients and smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Induction of nitric oxide synthase in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and I

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FJAS-100000021

21 January 2018

Identifiers

DOI

10.1081/JAS-100000021

1 reference

24 November 2017

1 reference